 11. Males must agree to use a latex condom during any sexual contact with FCBP while participating in the study and for 28 days following discontinuation from this study, even if he has undergone a successful vasectomy. Male subjects enrolled in Cohort B must agree to use a latex condom during any sexual contact with FCBP while participating in the study and until 3 months after last dose of daratumumab. 